Results 161 to 170 of about 31,703 (224)

Discordant Vitamin B12 Results in an IgA Nephropathy Patient. [PDF]

J Clin Lab Anal
Portakal O, Işlak N, Binici MŞ, Büyükaşik Y.   +3 more
europepmc   +1 more source

Evaluation of objective nutritional indices as predictors of renal progression in IgA nephropathy patients. [PDF]

Front Nutr
Zhou W, Yang B, Zhou K, Cui L, Wang L, Yang M, Yang Y.   +6 more
europepmc   +1 more source

Precision targeting of gut-kidney axis: mucosal immunomodulation in IgA nephropathy-a perspective. [PDF]

Front Med (Lausanne)
Sun LH, Yang XX.
europepmc   +1 more source

Correction: A case of membranoproliferative glomerulonephritis-type IgA nephropathy modified by nintedanib. [PDF]

CEN Case Rep
Kunisho Y, Sofue T, Nagano H, Higashitani M, Shiga T, Shiraishi A, Aoki Y, Onishi K, Ibuki E, Minamino T.   +9 more
europepmc   +1 more source

Efficacy of semaglutide in IgA nephropathy with obesity: a case report. [PDF]

BMC Nephrol
Li H, Jia J, Wei L, Shang W, Liu Y.
europepmc   +1 more source

Rapidly Progressive IgA Nephropathy in a Patient With a History of Breast Cancer: A Case Report and Literature Review. [PDF]

Case Rep Nephrol
Montesinos RL, Marca EQ, Torrico CA, Herbas DS, Limachi LC, Arenas ZT, Mamani WV.   +6 more
europepmc   +1 more source

Generic Controlled-Release Budesonide in IgA Nephropathy - A Single Center Retrospective Study. [PDF]

Kidney Int Rep
Bagchi S, Bhowmik D, Agarwal SK.
europepmc   +1 more source

Inhibition of soluble epoxide hydrolase ameliorates renal injury in IgA nephropathy by restoring epoxyeicosatrienoic acids. [PDF]

iScience
Yin HH, Fu X, Qiao Q, Yang E, Liu YN, Bai Y, Huang L, Chen YY, Huang ZY, Yu DC, Dai P, Pan QJ, Meng YW, Yin SY, Liu X, Nie S, Deng BQ, He Y, Liu JY.   +18 more
europepmc   +1 more source

Effect of finerenone on proteinuria reduction in IgA nephropathy. [PDF]

Ren Fail
Yu G, Wang M, Zhang X, Tao J, Zhao J, Liu S, Zhou S, Zhou J, Ren P, Cheng J, Chen J.   +10 more
europepmc   +1 more source